// App-Quantinova.ai

OC 13.2 : Convalescent Plasma Therapy Does Not Increase the Risk of Thromboembolism in The Treatment of COVID-19: A Systematic Review and Meta-Analysis

Researchers

Presenter

  • P. Li

Principal Investigators

  • A. Li

  • P. Yu

  • M. Khalid

  • M. Laureano

  • M. Crowther

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • University of Ottawa, Ottawa, ON, Canada

  • McMaster University Hamilton Health Sciences, Hamilton, ON, Canada

  • McMaster University, Michael G. DeGroote School of Medicine, Hamilton, ON, Canada

  • McMaster University, Michael G. DeGroote School of Medicine, Hamilton, ON, Canada

  • McMaster University, Internal Medicine, Hamilton, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A